Sort
50,496 grants matching “lung cancer”
Novel Targets for Vaccine Therapy
$960,254Claudia Palena · Division Of Basic Sciences - Nci · ZIC · FY2010 · CA
Alveolar Tissuegenesis in Murine Acute Lung Injury
$960,149William J. Martin · National Institute Of Environmental Health Sciences · Z01 · FY2008 · ES
Novel approaches to improve prediction of cancer-associated thrombosis
$960,071Keith R. McCrae · Cleveland Clinic Lerner Com-Cwru · U01 · FY2020 · HL
United for Health Equity - Living PDX Program (U4HELPP)
$960,065Jose G. Trevino · Virginia Commonwealth University · U54 · FY2024 · CA
Vaccine and immunotherapy strategies for cancer and viruses causing cancer
$960,045Jay A Berzofsky · Division Of Clinical Sciences - Nci · ZIA · FY2022 · CA
Mechanisms governing metastatic dormancy and reactivation
$959,998Filippo G Giancotti · University Of Tx Md Anderson Can Ctr · R35 · FY2020 · CA
Mechanisms governing metastatic dormancy and reactivation
$959,998Filippo G Giancotti · University Of Tx Md Anderson Can Ctr · R35 · FY2016 · CA
Mechanisms governing metastatic dormancy and reactivation
$959,998Filippo G Giancotti · University Of Tx Md Anderson Can Ctr · R35 · FY2018 · CA
Mechanisms governing metastatic dormancy and reactivation
$959,998Filippo G Giancotti · University Of Tx Md Anderson Can Ctr · R35 · FY2017 · CA
Mechanisms governing metastatic dormancy and reactivation
$959,994Filippo G Giancotti · Columbia University Health Sciences · R35 · FY2021 · CA
The Antigen Targeting Core
$959,871Maria Parkhurst · Division Of Basic Sciences - Nci · ZIC · FY2021 · CA
An Improved Method of Delivering a Sclerosing Agent for the Treatment of a Malignant Pleural Effusion.
$959,737Glenn W Laub · Tdl Innovations, Llc · R44 · FY2020 · CA
Integrative approaches to elucidate p53 transcriptional networks during carcinogenesis
$959,618Laura D Attardi · Stanford University · R35 · FY2025 · CA
Investigating molecular and cellular mechanisms of SCLC development to identify novel therapeutic strategies
$959,562Julien Sage · Stanford University · R35 · FY2025 · CA
Novel Stem Cell Immunotherapy for MDR-Tuberculosis
$959,375Chinnaswamy Jagannath · Methodist Hospital Research Institute · R01 · FY2022 · AI
University of Arizona Cancer Prevention Clinical Trials Network (UA CP-CTNet)
$959,375H-H. Sherry Chow · University Of Arizona · UG1 · FY2019 · CA
Novel Stem Cell Immunotherapy for MDR-Tuberculosis
$959,375Chinnaswamy Jagannath · Methodist Hospital Research Institute · R01 · FY2023 · AI
2/3: The Chicago Cancer Health Equity Collaborative (ChicagoCHEC)
$959,357Christina Ciecierski · Northeastern Illinois University · U54 · FY2024 · CA
Biomarker Investigations for Clinical Trials
$959,273Liang Cao · Division Of Basic Sciences - Nci · ZIC · FY2019 · CA
Forging Translational Glycobiologists: Intermeshing Glycoscience Training and Clinical Education
$958,467Robert Sackstein · Brigham And Women'S Hospital · K12 · FY2022 · HL
Forging Translational Glycobiologists: Intermeshing Glycoscience Training and Clinical Education
$958,467Robert Sackstein · Brigham And Women'S Hospital · K12 · FY2021 · HL
Forging Translational Glycobiologists: Intermeshing Glycoscience Training and Clinical Education
$958,467Robert Sackstein · Brigham And Women'S Hospital · K12 · FY2020 · HL
Forging Translational Glycobiologists: Intermeshing Glycoscience Training and Clinical Education
$958,467Robert Sackstein · Brigham And Women'S Hospital · K12 · FY2019 · HL
Regulation Of Intracellular Iron Metabolism
$958,368Tracey A. Rouault · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2013 · HD
Novel Stem Cell Immunotherapy for MDR-Tuberculosis
$958,345Chinnaswamy Jagannath · Methodist Hospital Research Institute · R01 · FY2024 · AI